Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the Future
Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the Future
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Alzheimer’s disease (AD) is the major cause of dementia in the elderly. The biochemical changes that precede AD may be present up to 20 years before the clinical manifestation of the disease. The translational development of AD biomarkers may be theoretically achieved via two different strategies: the first strategy can be defined as ‘knowledge-bas...
Alternative Titles
Full title
Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the Future
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_21709402
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_21709402
Other Identifiers
ISSN
1660-2854
E-ISSN
1660-2862
DOI
10.1159/000327756
